(Q43204898)

English

A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder

scientific article published on 22 December 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

1 reference

based on heuristic

inferred from title

author name string

Pál Czobor

1

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

Phil Skolnick

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

Bernard Beer

3

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

Arnold Lippa

4

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

publication date

22 December 2009

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

CNS Neuroscience & Therapeutics

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

16

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

63-75

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2009.00109.X

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2009.00109.X

21 January 2018

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized anxiety disorder: nature and course

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modifying quinolone antibiotics yields new anxiolytics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kava kava: examining new reports of toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selecting pharmacotherapy for generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anxioselective anxiolytics: can less be more?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABA-A receptors: a viable target for novel anxiolytics?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxiety

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized anxiety disorder in primary care: the precursor/modifier pathway to increased health care utilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical presentation of generalized anxiety in primary-care settings: practical concepts of classification and management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20041911

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1755-5949.2009.00109.X

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6493815

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43204898&oldid=1983694845"